Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 13/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | MYC | P01106 | 1/20 | 0.40 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7216175 | 0.83 | PTGS2 (0.59) | PTGS2KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL7210911 | 0.81 | PTGS2 (0.64) | PTGS2KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL7215413 | 0.78 | PTGS2 (0.54) | PTGS2PTGS1MAOB | |
| SCHEMBL7210861 | 0.77 | PTGS2 (0.71) | PTGS2KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL7210876 | 0.77 | PTGS2 (0.56) | PTGS2KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL7216743 | 0.76 | PTGS2 (0.74) | PTGS2KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL3831175 | 0.76 | PTGS2 (1.00) | PTGS2KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL7211888 | 0.75 | PTGS2 (0.59) | PTGS2KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL6517559 | 0.73 | PTGS2 (0.89) | PTGS2KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL7216986 | 0.73 | PTGS2 (0.64) | PTGS2KDM4EALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1369415-A1 | Substituted pyrrolyl compounds for the treatment of inflammation | G.D. SEARLE & CO. (US) | 2003-12-10 | — | — | EP | claimed |
| EP-0946507-A1 | SUBSTITUTED PYRROLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1999-10-06 | — | — | EP | claimed |
| WO-1998025896-A1 | SUBSTITUTED PYRROLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1998-06-18 | — | — | WO | claimed |
| EP-1369415-A1 | Substituted pyrrolyl compounds for the treatment of inflammation | G.D. SEARLE & CO. (US) | 2003-12-10 | — | — | EP | disclosed |
| US-5935990-A | PYRROLYL DERIVATIVES HAVING AT POSITION 1 OR 5 A PHENYL SUBSTITUTED WITH METHYLSULFONYL OR AMINOSULFONYL; INHIBIT CYCLOOXYGENASE-2 FOR USE TREATMENT OF INFLAMMATION, AS AN ANALGESIC, OR AS AN ANTIPYRETIC | G.D. SEARLE & CO. (US) | 1999-08-10 | — | — | US | disclosed |